*Corresponding author:Ashique Ali Arain, Consultant Family Physician, Assistant Professor, Department of Pharmacology, Isra University Hyderabad
Received: June 27, 2018; Published: July 06, 2018
To view the Full Article Peer-reviewed Article PDF
Background: World is now moving towards the natural therapies due to many reasons not the topic of discussion. Majority of the available allopathic drugs are derived from the natural primary sources either from the animals or plants. Garlic and its derivative have been tested for many illnesses like hyperlipidemia, anti-platelet aggregation and HTN the current study focused on exploring the mechanism of glucose lowering properties of the S-allylcysteine, a garlic derivative.
Methodology: Rats were randomly divided into 3 groups with 10 rats in each group A was +ve control with no intervention, group B was kept –ve control given alloxon to induce hyperglycemia only, group C was given alloxon and S-allylcysteine . Blood sample were drawn after 7, 14 and 21 days to assess glucose random levels and plasma insulin concentrations. SPSS version22 using ANOVA as statistical technique was applied for data analysis.
Results: There was a significant reduction in blood glucose levels from 300+81.3mg/dl 364 +43.16and 218.+36.38mg/dl in S-allylcysteine treated group at 7, 14 and 21 days respectively with p-value 0.0001. Similarly serum insulin levels were also improved from3.87+2.16, 8.0+1.6and 11.5 +1.69U/Lin s-allyl cysteine group p-value 0.000021.
Conclusion: Alloxon induced hypo-insulinemia was successfully corrected by S-allyl cysteine fitting it into insulin secretogogue category.
Keywords: Hyperglycemia; Alloxon; Insulin; SAC; Insulin Secretion; Vitamin B12; GI diseases; Glibenclamide; Non-Interventional; Anti-Metastatic; Insulin Resistance